Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 17551-17600 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06977815
Non-randomized Clinical Trial on Cognitive Stimulation With Virtual Reality in Patients With Mild Cognitive Impairment
NARecruiting
60 participants
Started: Oct 4, 2024 · Completed: Mar 31, 2026
3 conditions1 sponsor1 location
NCT06827288
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
NARecruiting
500 participants
Started: Oct 4, 2024 · Completed: Mar 31, 2028
1 condition4 sponsors1 location
NCT06615505
ASCEND: A Clinical Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs
PHASE2Recruiting
110 participants
Started: Oct 4, 2024 · Completed: Apr 30, 2026
3 conditions1 sponsor5 locations
NCT06494085
Pressure Muscle Index and Threshold of Over-assistance During Pressure Support Ventilation
N/ARecruiting
20 participants
Started: Oct 4, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06332560
Pain in Endometriosis And the Relation to Lifestyle
NARecruiting
250 participants
Started: Oct 4, 2024 · Completed: May 31, 2027
2 conditions15 sponsors5 locations
NCT04876950
Post Discharge After Surgery Virtual Care with Remote Automated Monitoring Technology-2 (PVC-RAM-2) Trial
NARecruiting
2,000 participants
Started: Oct 4, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor2 locations
NCT06655844
Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain
NARecruiting
50 participants
Started: Oct 4, 2024 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT06421155
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
NARecruiting
20 participants
Started: Oct 4, 2024 · Completed: Jun 14, 2028
4 conditions1 sponsor1 location
NCT06392932
Esophageal Temperature During PVI Using Q-DOT Micro
NARecruiting
30 participants
Started: Oct 4, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06644430
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
N/ARecruiting
470 participants
Started: Oct 4, 2024 · Completed: Dec 30, 2025
5 conditions1 sponsor1 location
NCT06629051
6-year Follow-up Data After the Berberine Intervention Trial
N/ARecruiting
891 participants
Started: Oct 4, 2024 · Completed: Dec 31, 2024
3 conditions7 sponsors1 location
NCT06788379
CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes
N/ARecruiting
160 participants
Started: Oct 4, 2024 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT06392789
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors
NARecruiting
60 participants
Started: Oct 4, 2024 · Completed: Jun 30, 2026
4 conditions2 sponsors1 location
NCT06392711
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
PHASE1Recruiting
36 participants
Started: Oct 4, 2024 · Completed: Nov 30, 2028
3 conditions1 sponsor1 location
NCT06274554
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
PHASE3Recruiting
120 participants
Started: Oct 4, 2024 · Completed: Dec 31, 2029
2 conditions2 sponsors1 location
NCT06603103
Prospective Randomized Study Comparing the SpheriKA® (MEDACTA) and Origin® (SYMBIOS) Prostheses During Total Knee Replacement Using the Kinematic Alignment Technique
NARecruiting
120 participants
Started: Oct 3, 2024 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT07139509
Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma
PHASE1Recruiting
18 participants
Started: Oct 3, 2024 · Completed: Dec 30, 2028
1 condition2 sponsors1 location
NCT06170645
Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue
NARecruiting
60 participants
Started: Oct 3, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06599736
A Study of RhinAer Stylus for Treating Chronic Rhinitis
NARecruiting
25 participants
Started: Oct 3, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor2 locations
NCT06690801
Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome
N/ARecruiting
1,260 participants
Started: Oct 3, 2024 · Completed: Feb 1, 2029
1 condition2 sponsors10 locations
NCT06315894
Supervised Computerized Active Program for People With Post-COVID Syndrome (SuperCAP Study)
NARecruiting
60 participants
Started: Oct 3, 2024 · Completed: Sep 3, 2025
1 condition3 sponsors1 location
NCT06415474
Evolution of the Lymphocyte Phenotype in Patients with Infection in Intensive Care Unit
NARecruiting
80 participants
Started: Oct 3, 2024 · Completed: Nov 3, 2026
4 conditions1 sponsor1 location
NCT06578078
A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
PHASE3Recruiting
94 participants
Started: Oct 3, 2024 · Completed: Dec 30, 2026
2 conditions1 sponsor6 locations
NCT06686472
Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
PHASE2Recruiting
66 participants
Started: Oct 3, 2024 · Completed: Dec 10, 2024
1 condition1 sponsor1 location
NCT06596473
A Study of BG-C477 in Participants With Advanced Solid Tumors
PHASE1Recruiting
21 participants
Started: Oct 3, 2024 · Completed: Oct 27, 2028
1 condition1 sponsor21 locations
NCT07095205
PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.
PHASE4Recruiting
14 participants
Started: Oct 3, 2024 · Completed: Sep 30, 2029
1 condition3 sponsors1 location
NCT06635005
A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women
NARecruiting
30 participants
Started: Oct 3, 2024 · Completed: Mar 31, 2026
2 conditions2 sponsors1 location
NCT06328647
Quantra Point-of-Care Hemostasis Monitoring
NARecruiting
666 participants
Started: Oct 3, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05561595
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
NARecruiting
195 participants
Started: Oct 3, 2024 · Completed: Mar 31, 2027
6 conditions3 sponsors1 location
NCT06482333
Timing of Resumption of Direct Oral Anticoagulants Following Polypectomy
NARecruiting
194 participants
Started: Oct 3, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06570603
Targeting Components of Distress Tolerance
NARecruiting
240 participants
Started: Oct 3, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05558059
Imaging Retinal Vasculature in Infant Eyes
N/ARecruiting
16 participants
Started: Oct 3, 2024 · Completed: Aug 31, 2027
1 condition3 sponsors2 locations
NCT06106529
REDucing Hot FLASHes in Women Using Endocrine Therapy.
PHASE3Recruiting
260 participants
Started: Oct 3, 2024 · Completed: Jan 1, 2029
2 conditions1 sponsor1 location
NCT06559891
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
NARecruiting
261 participants
Started: Oct 3, 2024 · Completed: Aug 15, 2028
1 condition3 sponsors34 locations
NCT06159504
Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania
EARLY_PHASE1Recruiting
3,040 participants
Started: Oct 3, 2024 · Completed: Dec 31, 2026
2 conditions5 sponsors1 location
NCT06854094
Consolidation Therapy with Cladribine in Relapsing Multiple Sclerosis Patients
N/ARecruiting
70 participants
Started: Oct 3, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT06806930
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
PHASE2Recruiting
90 participants
Started: Oct 3, 2024 · Completed: Oct 31, 2028
4 conditions1 sponsor1 location
NCT06825624
ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
PHASE1Recruiting
560 participants
Started: Oct 3, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06661473
Interventional Study Exploring the Occurrence of Surgical Site Infections.
NARecruiting
105 participants
Started: Oct 3, 2024 · Completed: Jun 30, 2025
3 conditions1 sponsor8 locations
NCT06876350
Woodcasting Versus Thermoplast Splint in CMC Arthroplasty
NARecruiting
26 participants
Started: Oct 3, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06596772
A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
PHASE3Recruiting
458 participants
Started: Oct 3, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor60 locations
NCT06700187
Frequency of Interrupting Sitting and Cognitive Function
NARecruiting
33 participants
Started: Oct 3, 2024 · Completed: Oct 30, 2025
2 conditions1 sponsor1 location
NCT07029126
Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
N/ARecruiting
300 participants
Started: Oct 3, 2024 · Completed: Mar 30, 2026
1 condition2 sponsors10 locations
NCT06627855
Effectiveness of the Fascial Distortion Model in Temporomandibular Disorders: A Randomized Sham-controlled Trial
NARecruiting
30 participants
Started: Oct 3, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06460519
The Prevalence of the Aortic to Radial Pressure Gradient in States of Shock, Outside the Context of Cardiac Surgery, a Prospective Study
N/ARecruiting
180 participants
Started: Oct 3, 2024 · Completed: Nov 3, 2026
1 condition1 sponsor5 locations
NCT06628375
A Multimodal Study of the Relationship Between Exposure to Endocrine Disruptors and Occurrence of Hypospadias - HYPOLLUT
N/ARecruiting
200 participants
Started: Oct 3, 2024 · Completed: Oct 3, 2027
1 condition1 sponsor1 location
NCT06624930
Behaviour Change for Cancer Survivors Trial
NARecruiting
236 participants
Started: Oct 3, 2024 · Completed: May 31, 2029
2 conditions3 sponsors1 location
NCT06519955
Can PLIA Reduce Early Post-operative Pain After PAO Surgery?
PHASE2/PHASE3Recruiting
120 participants
Started: Oct 3, 2024 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06634199
Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients
N/ARecruiting
50 participants
Started: Oct 3, 2024 · Completed: Nov 4, 2027
2 conditions1 sponsor22 locations
NCT06645587
Targeting Repetitive Behaviors in Autism Spectrum Disorder Via Transcranial Direct Current Stimulation
NARecruiting
78 participants
Started: Oct 3, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors1 location